HBIO Stock Analysis: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$0.50
-0.04 (-6.65%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 11, 2026
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HBIO is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HBIO is down 15.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $0.50, which is considered oversold relative to its 30-day fair value range of $0.57 to $0.69. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.3) compared to its historical average (6.9). Remarkably, the market is currently pricing in an annual earnings decline of 8.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $0.48, while resistance sits at $0.63. Short-term momentum is weak, with the stock down 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+299.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $0.48, while resistance sits at $0.63. Short-term momentum is weak, with the stock down 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.00 (+299.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.57 -
$0.69
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding HBIO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.7%)
- BULLISH: Trading 299.3% below Wall St target ($2.00)
- WARNING: Recommendation downgraded due to -15.4% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.57 -
$0.69
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.48
Resistance Level
$0.63
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
5.27
Wall Street Target
$2.00
(+299.3%)
Revenue Growth (YoY)
-6.3%
Earnings Growth (YoY)
-80.3%
Profit Margin
-61.6%
Valuation Discount vs History
-8.4% cheaper
PE vs Historical
5.3 vs 6.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.4%
(market-implied from PE analysis)
1-Year Target
$0.46
(-8%)
2-Year Target
$0.42
(-16%)
3-Year Target
$0.38
(-23%)
3-Yr Target (if PE normalizes)
(PE: 5→7)
$0.50
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 216.7%)
$7.15
(+1327%)
Base:
(SPY PE: 5.3, Growth: 216.7%)
$1.69
(+238%)
Bear:
(PE: 4.5, Growth: 216.7%)
$1.44
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.3 to 6.9
Stabilization Target:
$0.66
(+30.9%)
PE Expansion Potential:
+30.9%
Last updated: January 31, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced HBIO Option Strategies
Professional options setups generated by AI based on today's HBIO price and gamma walls.
